Patents expiring in 2035

US 9035072

Process of producing cycloalkylcarboxamido-indole compounds

Vertex Pharmaceuticals Incorporated · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9035061

Process for preparing a biphenyl-2-ylcarbamic acid

Theravance Biopharma R&D IP, LLC · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9034588

Monoclonal antibody therapy for pancreas cancer

PRECISION BIOLOGICS, INC. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9034318

Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9033919

Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids

Lutonix, Inc. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9034388

Bioeffective krill oil compositions

AKER BIOMARINE ANTARCTIC AS · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9034829

pH-sensitive polymer-drug conjugates for targeted delivery of therapeutics

Northwestern University · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040060

Hydrolytically degradable alkylene oxide based polymers

Nektar Therapeutics · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040233

Methods for detecting a Mycobacterium tuberculosis infection

The United States of America, DBA The Department of Veteran Affairs · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040241

Genetic markers of mental illness

SureGene LLC · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040550

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040527

Pyrimidinediamine kinase inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040626

Nanofibers and morphology shifting micelles

The Regents of the University of California · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040250

Binding interaction of proanthocyanidins with bacteria and bacterial components

United States of America as represented by the Secretary of the Air Force · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040721

Halogenated compounds for Photodynamic therapy

NANOQUANTUM SCIENCES, INC. · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040543

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040522

6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

Takeda Pharmaceutical Company Limited · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040658

Thiol-selective water-soluble polymer derivatives

Nektar Therapeutics · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040061

Topical formulation for administering a compound

Rigel Pharmaceuticals, Inc. · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040542

Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pryimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea

Vertex Pharmaceuticals Incorporated · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040157

Hollow nanoparticles and nanocomposites and methods of making hollow nanoparticles and nanocomposites

The Board of Regents of the University of Texas System · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040059

Recombinant bacterium capable of eliciting a protective immune response against C. perfringens

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040567

BAX agonist, compositions, and methods related thereto

The Board of Regents of the University of Texas System · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2866861

TRAITEMENT DES MIGRAINES CHRONIQUES PAR INHALATION D'OXYGENE

AIR LIQUIDE SANTE INT [FR] · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2875810

Pharmakologische Behandlung von Zwangsstörungen unter Verwendung von Stiripentol oder einer ähnlichen Verbindung

BIOCODEX [FR] · Granted Wed May 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue May 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2015077442

IMMUNOGÈNES DE POLLEN DE GRAMINÉE AINSI QUE PROCÉDÉS ET UTILISATIONS POUR LA MODULATION DE LA RÉPONSE IMMUNITAIRE

JOLLA INST ALLERGY IMMUNOLOG [US] · Granted Thu May 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2931112

IMMUNOGENES CONTRE PLUSIEURS POLLENS ET PROCEDES ET UTILISATIONS POUR MODULER LA REPONSE IMMUNITAIRE

LA JOLLA INST ALLERGY & IMMUNOLOGY [US] · Granted Thu May 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044391

Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery

The Board of Regents of the University of Texas System · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044419

Vaccine compositions compromising βs-crystallin for inducing immune responses against components of drusen

Northwestern University · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044454

Regulation of microvasculature occlusion

Northwestern University · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044442

Peptidomimetic compounds as immunomodulators

Aurigene Discovery Technologies Limited · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045731

Compositions and methods for improving the functional efficacy of stem cell-derived cardiomyocytes

The Regents of the University of California · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045559

Method for screening inhibitors of interleukin-32 (IL-32)

The Regents of the University of Colorado · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044381

Method for delivering drugs to the brain

Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044392

Nylon-3 co-polymers and synthetic lung surfactant compositions containing same

Northwestern University · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044420

Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses

IMMUNE DESIGN CORP. · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045541

CD47 antibodies and methods of use thereof

Inhibrx, Inc. · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045425

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044611

Systems and methods for selectively migrating cells using electric fields

The Regents of the University of California · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044516

Pharmaceutical compositions of conjugates formed from polymer derivatives having particular atom arrangements

Nektar Therapeutics · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044457

Anti-DR4 agonist antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9043996

Genetically modified major histocompatibility complex animals

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045496

N-substituted oxazinopteridines and oxazinopteridinones

Takeda Pharmaceutical Company Limited · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045476

Inhibition of quorum sensing-mediated processes in bacteria

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044473

Delivery of therapeutic compounds to the brain and other tissues

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044423

Alcoholic compositions having a lowered risk of acetaldehydemia

Deuteria Beverages, LLC · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044398

Abuse-deterrent pharmaceutical compositions of opiods and other drugs

Collegium Pharmaceutical, Inc. · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044451

Use of delta tocopherol for the treatment of lysosomal storage disorders

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)